glp-1 and neuroinflammation A schematic representation of the mechanism of glucagon-like peptide-1 Beyond diabetes and obesity: GLP‐1

24 hours after taking certain diabetes medications (like insulin or sulfonylureas, if youre using them together with GLP-1s) Between meals, when blood sugar naturally dips During or after exercise, especially if you havent eaten enough beforehand After dose changes, as your body adapts to stronger appetite-suppressing effects During rapid weight loss or dietary changes, when your energy intake is lower than usual Whos at higher risk

In the SURMOUNT-1 trial, tirzepatide 15 mg weekly achieved 20.9% WL over 72 weeks (vs

J ournal of Clinical Medicine, 8 (6), 817

These changes will affect fully insured large group commercial members, with a significant shift coming on January 1, 2025, when coverage for these medications will be discontinued altogether

Each one has practical differences worth knowing, and technique matters a lot more than which site you pick